In yesterday's Sunday Business cover story, I looked at the state of Baltimore's biotech industry, and compared it to its larger cousin to the south, in Montgomery County. Take a read.
Baltimore's biotechnology industry has made strides. Two biotech parks by the Johns Hopkins University and the University of Maryland now anchor the east and west sides of the city. A few dozen biotech startups have made their home here.
But Baltimore's nascent biotech industry doesn't yet have a breakout company — a darling of venture capitalists and Wall Street that has grown past the risky and unprofitable startup phase to achieve a steady stream of revenue and products in the pipeline.
A company like MedImmune in Montgomery County, which produces an H1N1 flu virus vaccine, among others.
To read the full, original article click on this link: BaltTech: Biotech: Baltimore needs its own MedImmune? - Gus Sentementes covers digital tech and innovation in Baltimore and beyond - baltimoresun.com
Author: Gus G. Sentementes
